{"generic":"Docosanol","drugs":["Abreva","Docosanol"],"mono":{"0":{"id":"925434-s-0","title":"Generic Names","mono":"Docosanol"},"1":{"id":"925434-s-1","title":"Dosing and Indications","sub":{"0":{"id":"925434-s-1-4","title":"Adult Dosing","mono":"<b>Herpes labialis:<\/b> apply TOPICALLY to lesions 5 times a day until lesions have healed"},"1":{"id":"925434-s-1-5","title":"Pediatric Dosing","mono":"<b>Herpes labialis:<\/b> 12 years of age and older, apply TOPICALLY to lesions 5 times a day until lesions have healed"},"3":{"id":"925434-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Herpes labialis<br\/>"}}},"3":{"id":"925434-s-3","title":"Contraindications\/Warnings","sub":[{"id":"925434-s-3-9","title":"Contraindications","mono":"hypersensitivity to docosanol<br\/>"},{"id":"925434-s-3-10","title":"Precautions","mono":"<ul><li>patients with history of allergic phenomena related to topical medications<\/li><li>use only to treat oral-facial herpes simplex on the lips and face<\/li><\/ul>"},{"id":"925434-s-3-11","title":"Pregnancy Category","mono":"Fetal risk cannot be ruled out. (TH)<br\/>"},{"id":"925434-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"925434-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Application site reaction (2.9%)<br\/>"},"6":{"id":"925434-s-6","title":"Drug Name Info","sub":{"0":{"id":"925434-s-6-17","title":"US Trade Names","mono":"Abreva<br\/>"},"2":{"id":"925434-s-6-19","title":"Class","mono":"Antiviral<br\/>"},"3":{"id":"925434-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"925434-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"925434-s-7","title":"Mechanism Of Action","mono":"Topical: Docosanol reduces viral replication and activity by effectively inhibiting the fusion between the plasma membrane and the herpes simplex virus envelope.<br\/>"},"8":{"id":"925434-s-8","title":"Pharmacokinetics","sub":[{"id":"925434-s-8-23","title":"Absorption","mono":"Topical: Minimal <br\/>"}]},"9":{"id":"925434-s-9","title":"Administration","mono":"<b>Topical<\/b><br\/>rub in gently to cover affected area completely <br\/>"},"10":{"id":"925434-s-10","title":"Monitoring","mono":"improvement in lesions<br\/>"},"11":{"id":"925434-s-11","title":"How Supplied","mono":"<b>Abreva<\/b><br\/>Topical Cream: 10 %<br\/>"},"13":{"id":"925434-s-13","title":"Clinical Teaching","mono":"<ul><li>Tell patient that drug is for herpetic lesions on lips and face only. Drug should not be used on genital herpes.<\/li><li>Avoid contact of drug with eyes.<\/li><li>This drug may cause application site reaction or headache.<\/li><\/ul>"}}}